(Q70049426)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2964956%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

title

Natural cytotoxicity in the neonate: high levels of lymphokine activated killer (LAK) activity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2964956%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

author name string

Montagna D

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2964956%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

Maccario R

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2964956%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

Ugazio AG

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2964956%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

Mingrat G

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2964956%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

Burgio GR

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2964956%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

publication date

1 January 1988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2964956%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Immunology

8 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2964956%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

volume

71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2964956%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2964956%20AND%20SRC:MED&resulttype=core&format=json

8 October 2019

page(s)

177-181

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2964956%20AND%20SRC:MED&resulttype=core&format=json

Studies on cytotoxicity generated in human mixed lymphocyte cultures. I. Time course and target spectrum of several distinct concomitant cytotoxic activities

8 October 2019

cites work

1 reference

12 December 2020

T cell nature of some lymphokine-activated killer (LAK) cells. Frequency analysis of LAK precursors within human T cell populations and clonal analysis of LAK effector cells

1 reference

12 December 2020

Cytotoxicity by cultured human lymphocytes: characteristics of effector cells and specificity of cytotoxicity

1 reference

12 December 2020

Distinction of anti-K562 and anti-allocytotoxicity in in vitro-stimulated populations of human lymphocytes

1 reference

12 December 2020

Disappearance of the NK effect after explantation of lymphocytes and generation of similar nonspecific cytotoxicity correlated to the level of blastogenesis in activated cultures

1 reference

12 December 2020

A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1)

1 reference

12 December 2020

Spontaneous release of a factor with properties of T cell growth factor from a continuous line of primate tumor T cells.

1 reference

12 December 2020

Postnatal expansion of the natural killer and keller cell population in humans identified by the monoclonal HNK-1 antibody

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

12 December 2020

Generation of T cell blasts with NK-like activity in human MLC: cellular precursors, IL 2 responsiveness, and phenotype expression

1 reference

12 December 2020

Natural killer cell function of human neonatal lymphocytes

1 reference

12 December 2020

Development of natural killer cell function in the human fetus

1 reference

12 December 2020

Lymphocyte subpopulations in the neonate: identification of an immature subset of OKT8-positive, OKT3-negative cells.

1 reference

12 December 2020

Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1.

1 reference

12 December 2020

Defective infant antiviral cytotoxicity to herpes simplex virus-infected cells

1 reference

12 December 2020

Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens

1 reference

12 December 2020

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells

1 reference

12 December 2020

Assignment of human natural killer (NK)-like cells to the T cell lineage. Single allospecific T cell clones lyse specific or NK-sensitive target cells via distinct recognition structures

1 reference

12 December 2020

Natural killer cells activated in a human mixed lymphocyte response culture identified by expression of Leu-11 and class II histocompatibility antigens

1 reference

12 December 2020

Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.

1 reference

12 December 2020

Lymphocyte subpopulations in the neonate: a subset of HNK-1-, OKT3-, OKT8+ lymphocytes displays natural killer activity

1 reference

12 December 2020

Characteristics of human NK clones: target specificity and phenotype

1 reference

12 December 2020

Analysis in human neonates of defective antibody-dependent cellular cytotoxicity and natural killer cytotoxicity to herpes simplex virus-infected cells

1 reference

12 December 2020

Immunologic Regulation of Fetal-Maternal Balance

1 reference

12 December 2020

Interleukin 2 regulates the expression of Tac antigen on peripheral blood T lymphocytes

1 reference

12 December 2020

Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells

1 reference

12 December 2020

Association of decreased natural and antibody-dependent cellular cytotoxicity and production of natural killer cytotoxic factor and interferon in neonates

1 reference

12 December 2020

The human lymphokine-activated killer cell system. V. Purified recombinant interleukin 2 activates cytotoxic lymphocytes which lyse both natural killer-resistant autologous and allogeneic tumors and trinitrophenyl-modified autologous peripheral bloo

1 reference

12 December 2020

Lymphokine-activated killer cells. Analysis of progenitors and effectors

1 reference

12 December 2020

Cytotoxic studies in human newborns: lessened allogeneic cell-induced (augmented) cytotoxicity but strong lymphokine-activated cytotoxicity of cord mononuclear cells

1 reference

12 December 2020

Natural Cell-Mediated Immunity

1 reference

12 December 2020

Identifiers

1 reference